RESEARCHER PROFILE

Talar Ahmad Merza Mohammad

Hawler Medical University

COVID-19 Clinical Research StudiesCancer Immunotherapy and BiomarkersPsoriasis: Treatment and PathogenesisImmunotherapy and Immune ResponsesFibromyalgia and Chronic Fatigue Syndrome Research

Talar Ahmad Merza Mohammad works in COVID-19 Clinical Research Studies, Cancer Immunotherapy and Biomarkers, Psoriasis: Treatment and Pathogenesis, Immunotherapy and Immune Responses, Fibromyalgia and Chronic Fatigue Syndrome Research. Recorded institutional associations include Hawler Medical University, University of Kurdistan Hewler.

30Publications

479Citations

10H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

← Return to the university profile

Talar Ahmad Merza Mohammad

Hawler Medical University

Selected research works

CAR-T cell combination therapy: the next revolution in cancer treatment

Biological causes of immunogenic cancer cell death (ICD) and anti-tumor therapy; Combination of Oncolytic virus-based immunotherapy and CAR T-cell therapy for ICD induction

MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers

Serum levels of serotonin as a biomarker of newly diagnosed fibromyalgia in women: Its relation to the platelet indices

Piperine suppresses inflammatory fibroblast-like synoviocytes derived from rheumatoid arthritis patients Via NF-κB inhibition

Correlation of hematological indices and ratios derived from them with FIQR scores in fibromyalgia

Pentoxifylline as a Novel Add-on Therapy for Major Depressive Disorder in Adult Patients: A Randomized, Double-Blind, Placebo-Controlled Trial

Combining nano-curcumin with catechin improves COVID-19-infected patient's inflammatory conditions

CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies

Potential anti-inflammatory effect of anti-HMGB1 in animal models of ICH by downregulating the TLR4 signaling pathway and regulating the inflammatory cytokines along with increasing HO1 and NRF2

Immunogenicity of COVID ‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta‐analysis

Efficacy of pentoxifylline for the treatment of bipolar I/II patients with treatment-resistant depression: A proof-of-concept, randomized, double-blind, placebo-controlled trial

siRNA-based therapy for gastric adenocarcinoma: what’s next step?

SHR0302 Improves Treg/Th17 Imbalance in Patients with Systemic Lupus Erythematosus

STA ‐21 regulates Th‐17/Treg balance and synovial fibroblasts functions in rheumatoid arthritis

The effects of nanocurcumin on immune-related factors in the ankylosing spondylitis patients: a double-blind, randomized, placebo‐controlled clinical trial

Dysfunction of anterior pituitary gland in women patients with recent fibromyalgia: A cross-sectional observational study

Decoding the immune Response: Analyzing PBMCs in ischemic stroke and Evaluating the effects of Rivaroxaban on gene expression

Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosis

Immunometabolic alterations induced by GBD surgery and adjunct pharmacotherapy with metformin, orlistat, statins, and ACE inhibitors

Ex vivo treatment with poly (I:C) alleviates the exhausted phenotype of tumor-infiltrating TCD8+ cells of gastric cancer patients

Expression of proliferation-related genes in BM-MSC-treated ALL cells in hypoxia condition is regulated under the influence of epigenetic factors in-vitro

Assessment of some prescribed drugs in the management of COVID-19 on the survival function: A preliminary report from a single center in Iraq

Ex vivo modulation of monocyte/macrophage phenotypes by all-trans retinoic acid in chemotherapy-induced peripheral neuropathy

Integrated pharmacological and Omega-3 therapy modulates immunometabolic pathways and neuro-ophthalmological outcomes in relapsing-remitting multiple sclerosis